newsfilter
← Latest News
GlobeNewswire·

Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business Results

STS101 EMERGE™ Phase 3 efficacy trial remains on track with announcement of topline data expected in second half of 2020 Company well-capitalized with cash, cash equivalents, and marketable...